首页> 外文OA文献 >Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

【2h】

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

机译：重组人5型腺病毒H101的经动脉注射与经动脉化学栓塞（TACE）相结合可改善不可切除的肝细胞癌（HCC）的总体生存率和无进展生存率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. 经动脉化疗栓塞术和重组人5型腺病毒H101联合治疗延长中晚期肝细胞癌患者总生存期:预后列线图研究 [J] . Chao-Bin He, Xiang-Ming Lao, Xiao-Jun Lin 癌症（英文版） . 2018,第003期
2. Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC) [J] . Xiao-jun Lin, Qi-jiong Li, Xiang-ming Lao, BMC Cancer . 2015,第1期

机译：重组人5型腺病毒H101的经动脉注射与经动脉化学栓塞（TACE）相结合可改善不可切除的肝细胞癌（HCC）的总体生存率和无进展生存率
3. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study [J] . Chao-Bin He, Xiang-Ming Lao, Xiao-Jun Lin Cancer Communications . 2017,第1期

机译：经动脉化学栓塞联合5型H101重组人腺病毒可延长中晚期肝细胞癌患者的总生存期：诺模图预后研究
4. Transarterial chemoembolization combined with recombinant human adenovirus type?5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study [J] . Chao-Bin He, Xiang-Ming Lao, Xiao-Jun Lin Chinese journal of cancer . 2017,第1期

机译：经动脉化学栓塞联合重组人5型H101腺病毒可延长中晚期肝细胞癌患者的总生存期：诺模图预后研究
5. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
6. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
7. Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC) [O] . Xiao-jun Lin, Qi-jiong Li, Xiang-ming Lao, 2015

机译：重组人5型腺病毒H101的经动脉注射与经动脉化学栓塞（TACE）相结合可改善不可切除的肝细胞癌（HCC）的总体生存率和无进展生存率
8. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. [O] . Chao-Bin He, Xiao-Jun Lin 2017

机译：炎症评分预测用经动脉化学栓塞和重组人5型腺病毒H101治疗的肝细胞癌患者的存活率。

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

著录项

引文网络

相似文献

相关主题

期刊订阅